Argenx receives positive CHMP opinion for CIDP treatment
28th April 2025 Uncategorised 0
VYVGART could be the first CIDP drug with a novel mechanism in 30 years

More: Argenx receives positive CHMP opinion for CIDP treatment
Source: News
VYVGART could be the first CIDP drug with a novel mechanism in 30 years

More: Argenx receives positive CHMP opinion for CIDP treatment
Source: News
© 1994 - 2026 B.M. Pharmaceuticals